Geron | GERN - Koszty Operacyjne





Koszty Operacyjne Zmiana Data
Amgen USD 4.78B 1.12B 2026-03
Bio Techne USD 241.42M 2.52M 2025-12
Cassava Sciences USD 13.55M 1.69M 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 359.47M 3.28M 2026-03
Genmab DKK 798M 235M 2025-12
Geron USD 58.8M 2.31M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 5.62B 4.5B 2026-03
MacroGenics USD 53.32M 13.68M 2025-12
Novartis USD 9.29B 507M 2026-03
Novavax USD 126.2M 23.62M 2025-12